Prognostic Nutritional Index Predicts Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome


Yuksel Y., KÖSE Ş.

Angiology, cilt.74, sa.8, ss.736-744, 2023 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 74 Sayı: 8
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1177/00033197221116203
  • Dergi Adı: Angiology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, CINAHL, EMBASE, Food Science & Technology Abstracts
  • Sayfa Sayıları: ss.736-744
  • Anahtar Kelimeler: contrast-induced nephropathy, inflammation, prognostic nutritional index, acute coronary syndrome
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

This study evaluated the effectiveness of prognostic nutritional index (PNI) in predicting contrast induced nephropathy (CIN) in patients with acute coronary syndrome (ACS). This study included 925 ACS patients (mean age 62.5 ± 12.4 years, 73.5% male); 604 were diagnosed as unstable angina pectoris/non–ST-elevation myocardial infarction (USAP/NSTEMI) and 321 as ST-elevation myocardial infarction (STEMI). The PNI formula was: 10 × serum albumin (g/dL) +.005 × total lymphocyte count (/mm3). The patients were divided into two groups: CIN (n = 232) and non-CIN (n = 693). Patients without CIN had a significantly lower PNI than patients with CIN (44.3 ± 6.9 vs 54.7 ± 7.4; P <.001). In the receiver operating characteristic (ROC) curve analysis, the cut-off value for PNI of 48.6 has 80% specificity and 81% sensitivity in predicting CIN (area under the ROC curve (AUC):.87, 95% CI [.84–.89]). PNI <48.6 (odds ratio (OR): 6.765, P <.001), pre-procedural creatinine levels (OR: 6.223, P <.001), left ventricular ejection fraction (LVEF) (OR:.960, P <.001), age (OR: 1.025, P =.005), diabetes mellitus (DM) (0R: 1.768, P =.006), contrast amount (OR: 1.003, P =.038), and having STEMI (OR:.594, P =.029) were found independently associated with CIN. PNI is a strong independent predictor of CIN in ACS patients.